Skip to main content

Mesalamine News

5-ASA Discontinuation Common Within First Year of Ulcerative Colitis Diagnosis in Youth

WEDNESDAY, Sept. 20, 2023 – For adolescents and young adults diagnosed with ulcerative colitis (UC), the rate of discontinuation of 5-aminosalicylic acid (5-ASA) maintenance treatment is high within...

Warner Chilcott Announces FDA Approval of New Ulcerative Colitis Product Delzicol

DUBLIN, Ireland, Feb. 5, 2013 – Warner Chilcott plc today announced that the United States Food and Drug Administration (FDA) has approved its new 400 mg mesalamine product indicated for the...

Lialda (Mesalamine) Now Approved in U.S. for Maintenance of Remission of Ulcerative Colitis

Lialda has been indicated for the induction of remission in patients with active, mild to moderate ulcerative colitis and is now also approved for the maintenance of remission of ulcerative colitis ...

Ask a question

To post your own question to this support group, sign in or create an account.

Further information

Related condition support groups

Crohn's Disease - Maintenance, Inflammatory Bowel Disease, Ulcerative Colitis, Crohn's Disease

Mesalamine patient information at Drugs.com